title: Managing anthracycline-induced cardiotoxicity: beginning with the end in mind.
authors.affiliation: Unit of Drug Sciences, Department of Medicine, University Campus Bio-Medico, Via Alvaro del Portillo 21, 00128 Rome, Italy.
authors.forename: Emanuela
authors.initials: E
authors.lastname: Salvatorelli
authors.affiliation: Unit of Drug Sciences, Department of Medicine, University Campus Bio-Medico, Via Alvaro del Portillo 21, 00128 Rome, Italy.|Unit of Clinical Pharmacology, Campus Bio-Medico University Hospital, Via Alvaro del Portillo 200, 00128 Rome, Italy.
authors.forename: Pierantonio
authors.initials: P
authors.lastname: Menna
authors.affiliation: Unit of Drug Sciences, Department of Medicine, University Campus Bio-Medico, Via Alvaro del Portillo 21, 00128 Rome, Italy.|Unit of Clinical Pharmacology, Campus Bio-Medico University Hospital, Via Alvaro del Portillo 200, 00128 Rome, Italy.
authors.forename: Giorgio
authors.initials: G
authors.lastname: Minotti
mesh_terms: D018943:Anthracyclines / Q000009:adverse effects*; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D066126:Cardiotoxicity / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006331:Heart Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic
keywords: Anthracyclines; cardiotoxicity; comorbidities; dexrazoxane; doxorubicin; heart failure; prevention; surveillance; survivors